Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Mallinckrodt
Cipla
AstraZeneca
Farmers Insurance
Boehringer Ingelheim
Citi
Colorcon
Chubb

Generated: August 17, 2017

DrugPatentWatch Database Preview

Apothecon Company Profile

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Applicant: Apothecon

Patents:0
Tradenames:77
Ingredients:47
NDAs:114
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
TEGOPEN
cloxacillin sodium
FOR SOLUTION;ORAL061453-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
PRINCIPEN
ampicillin/ampicillin trihydrate
CAPSULE;ORAL062888-001Mar 4, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
TRIMOX
amoxicillin
FOR SUSPENSION;ORAL062099-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
OXACILLIN SODIUM
oxacillin sodium
INJECTABLE;INJECTION050195-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Apothecon
VESPRIN
triflupromazine
SUSPENSION;ORAL011491-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Apothecon

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon
CAPOZIDE 50/15
captopril; hydrochlorothiazide
TABLET;ORAL018709-004Oct 12, 1984► Subscribe► Subscribe
Apothecon
CAPOZIDE 25/15
captopril; hydrochlorothiazide
TABLET;ORAL018709-001Oct 12, 1984► Subscribe► Subscribe
Apothecon
CAPOZIDE 50/25
captopril; hydrochlorothiazide
TABLET;ORAL018709-003Oct 12, 1984► Subscribe► Subscribe
Apothecon
STADOL PRESERVATIVE FREE
butorphanol tartrate
INJECTABLE;INJECTION017857-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Apothecon
CAPOZIDE 25/25
captopril; hydrochlorothiazide
TABLET;ORAL018709-002Oct 12, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
McKesson
Johnson and Johnson
Moodys
McKinsey
Baxter
Colorcon
Novartis
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot